ALTAltimmune, Inc.

Nasdaq altimmune.com


$ 7.24 $ 0.06 (0.83 %)    

Friday, 26-Apr-2024 15:59:56 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 7.26
$ 7.08
$ 7.25 x 200
$ 0.00 x 0
$ 6.92 - $ 7.41
$ 2.09 - $ 14.84
2,250,760
na
386.57M
$ 0.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-27-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-15-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-10-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 03-27-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-03-2017 03-31-2017 10-Q
29 03-14-2017 12-31-2016 10-K
30 11-04-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-11-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-05-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-11-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-05-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-altimmune-lowers-price-target-to-12

HC Wainwright & Co. analyst Patrick Trucchio maintains Altimmune (NASDAQ:ALT) with a Buy and lowers the price target fro...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

 b-riley-securities-reiterates-buy-on-altimmune-maintains-20-price-target

B. Riley Securities analyst Mayank Mamtani reiterates Altimmune (NASDAQ:ALT) with a Buy and maintains $20 price target.

 rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

 why-is-obesity-drug-developer-altimmune-stock-trading-lower-on-wednesday

Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipos...

 altimmune-q4-gaap-eps-054-misses-043-estimate-sales-3700k-up-from-11000k-yoy

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.43) by...

 earnings-scheduled-for-march-27-2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

 altimmunes-earnings-outlook
Altimmune's Earnings Outlook
03/26/2024 15:00:59

 cramer-calls-datadog-dynamite-puts-sofi-in-dog-house-what-the-heck-is-going-on

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter.

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

 altimmune-stock-surges-kerrisdale-remains-short-what-you-need-to-know

Altimmune shares are trading higher Monday despite a lack of company-specific news. Kerrisdale Capital told Benzinga on Monday ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION